MDVIP | AI Transformation Index

MDVIP is structurally well-positioned against AI disruption because the product it sells — licensed physician access and relationship continuity — is legal...

MDVIPHealthcare (Medical - Healthcare Information Services)Charlesbank Capital Partners

Overview

MDVIP operates a national membership-based primary care network, recruiting and supporting ~1,400 affiliated physicians to run smaller, relationship-intensive practices while charging patients ~$1,800–$2,200/year in direct membership fees for enhanced access and preventive care.

Executive Summary

MDVIP is structurally well-positioned against AI disruption because the product it sells — licensed physician access and relationship continuity — is legally and practically irreplaceable by AI, giving it a durability profile uncommon in healthcare services. The AI opportunity is real but bounded: administrative compression, ambient documentation, and longitudinal member analytics can improve unit economics and physician capacity meaningfully, and there is a credible path to using the 430,000-member dataset to enter employer and payer value-based arrangements. The strategic implication is that MDVIP should invest confidently in AI to improve the administrative envelope around clinical care and expand the between-visit member value proposition, while recognizing that the core moat — physician licensure, trust, and relationship depth — does not require AI defense so much as operational execution.

Durability

How resilient is this business against AI disruption?

FactorValue

Market Substitutability

8

Profit Pool Migration

7

Barrier to Entry

9

Disintermediation Exposure

7

Switching Costs

7
Total76.0
×

Opportunity

How big a deal is AI for this business?

FactorValue

AI Applicability

5

Improvement Magnitude

6

Transformation Upside

6

Domain Intelligence Amplification

6
Total57.5

66.1

Ciridae AI Score

Durability Rationale

MDVIP's durability is anchored by the irreducible combination of medical licensure requirements, clinical liability, and the patient willingness to pay a premium specifically for a trusted human physician relationship — none of which AI can substitute structurally or legally. The business sits close enough to the clinical delivery layer that it avoids the fate of a pure administrative middleman, and it provides genuine operational value to affiliated physicians that makes bypass unattractive. The primary durability risk is not AI substitution but rather well-capitalized competitors building equivalent physician network infrastructure, or physicians defecting to independent direct primary care models as operational support becomes more commoditized by software.

Opportunity Rationale

AI is a meaningful but not transformative deal for MDVIP — the biggest leverage points are administrative compression (ambient scribing, documentation, prior auth automation) that gives back clinical time to physicians and reduces MDVIP's corporate cost per affiliated physician, and population-level analytics across 430,000 longitudinal members that could improve preventive care quality and open employer/payer market adjacencies. The transformation ceiling is set by the fact that the core product — physician presence, physical examination, and human relationship — is genuinely outside AI's reach, which limits AI applicability breadth even as the opportunity within the reachable surface area is real.

Key Risks

The durability argument assumes the physician-patient relationship remains the irreducible core of what members pay for — but if AI-native health companions (continuous monitoring, ambient diagnosis, agentic care coordination) achieve sufficient clinical trust and regulatory acceptance, the willingness-to-pay for a human physician relationship could erode faster than the regulatory environment suggests today, particularly among younger cohorts less attached to the concierge model.

The opportunity argument assumes MDVIP can capture the AI-enabled administrative and analytics value at the corporate platform level — but if AI tools commoditize physician administrative support (any DPC physician can use ambient scribing independently), the operational differentiation MDVIP provides may compress, reducing physician dependency on the MDVIP platform and weakening both the opportunity and the D4 position simultaneously.

Company Overview

HeadquartersBoca Raton, Florida
Products / Services
Membership-based personalized primary carepreventive and wellness-focused carephysician-affiliate practice transition and succession supportclinical education and quality programsmember services, digital tools and administrative support.
Deal Partners

AI & Tech Initiatives

NameDescription
AI-first payments engineering and agentic developmentAI-first engineering workflow for rebuilding MDVIP’s payments integration layer on Azure using Claude Code as the primary development interface, with agentic code generation, automated testing and continuous deployment; the posting describes this as a production engineering practice rather than autocomplete assistance.
Applied AI analytics and generative-AI prototypingApplied-AI analytics program using generative-AI tools, LLMs, AI coding assistants and AI platforms to accelerate analytics, evaluate AI agents, and prototype intelligent document analysis, natural-language analytics interfaces and automated quality assurance.

PE / Ownership History

EventDetails
Goldman Sachs Asset Management and Charlesbank Capital Partners acquire majority ownership
October 14, 2021
The private-equity business of Goldman Sachs Asset Management and funds affiliated with Charlesbank Capital Partners completed the acquisition of MDVIP from Leonard Green and Summit Partners, obtaining majority ownership. Financial terms were not disclosed. Summit and Leonard Green exited their ownership positions according to the announcement.
Leonard Green & Partners acquires majority ownership from Summit Partners
November 15, 2017
Leonard Green acquired a majority interest from Summit Partners; Summit remained a minority investor. Financial terms were not disclosed. Alyse Wagner was identified in the announcement as Leonard Green’s Partner commenting on the transaction.
Summit Partners reacquires MDVIP from Procter & Gamble
May 2, 2014
Summit agreed to acquire MDVIP from Procter & Gamble, with closing subject to customary approvals. Terms were not disclosed. Bret Jorgensen returned as executive chairman and later became CEO.
Procter & Gamble acquires MDVIP from Summit Partners
2009
Summit sold MDVIP to Procter & Gamble; transaction terms were not identified in the reviewed sources. P&G later pursued divestiture as part of portfolio rationalization.
Summit Partners makes an initial minority investment in MDVIP
2004
Summit Partners initially invested in MDVIP and held a minority interest. The investment preceded MDVIP’s sale to Procter & Gamble.

Executives

NameBackground
Larry Kutscher
Chief Executive Officer and Chairman
More than 30 years in executive leadership; former CEO of A Place for Mom, CEO of TravelClick, CEO of Register.com, General Manager of Dun & Bradstreet’s Small Business Group, and American Express executive. He became MDVIP CEO in August 2024 and added the chairman role in August 2025.
Matt Grossman
Chief Financial Officer
Joined MDVIP in 2016 as Controller and expanded into company-wide finance and HR leadership. Previously Controller at Charter Schools USA and Audit Manager at a regional public accounting firm; licensed CPA with finance and accounting degrees from Florida Atlantic University.
Ben Stapleton
Chief Operating Officer
Joined in January 2025. Previously COO of Crossroads Treatment Centers, where he led 800 employees and 160 providers across more than 100 centers; previously Chief Clinical Operations Officer at Everside Health and held corporate-development and dialysis-operations leadership roles at DaVita. Earlier experience includes Morgan Stanley, Deutsche Bank and Greywolf Capital.
John Kane
Chief Technology Officer
Technology executive with more than two decades leading engineering, architecture and analytics teams. Former Senior Vice President of Engineering and divisional CTO for Payments at Billtrust, with prior senior roles at TravelClick, Torus Insurance, JetBlue and Towers Perrin Reinsurance.
Andrea Klemes, DO, FACE
Chief Medical Officer
Board-certified internist and endocrinologist. Previously held personal-healthcare, women’s-health and digestive-wellness roles at Procter & Gamble, served as North American Medical Director for bone health, and practiced endocrinology for 10 years in Florida; has led clinical and medical organizations and published clinical research.
Neal Keltz
Chief Product Officer
Joined MDVIP in April 2025. Brings more than 15 years of product, revenue, go-to-market and operations experience, including product initiatives at Togetherwork, TravelClick and American Express.
Jessica Jacobs
Chief Marketing Officer
Joined MDVIP in January 2025; leads the company’s marketing and communications function. Detailed prior-role history was not publicly established in the reviewed sources.
Theresa Graff
Chief Human Resources Officer
Joined MDVIP in January 2025 and leads human-resources strategy and talent organization. Detailed prior-role history was not publicly established in the reviewed sources.
Ken Nazemetz
Executive Vice President, Physician Development
Joined MDVIP in 2008 and has led physician development, including transitions and growth of the affiliated physician network. Detailed prior-role history was not publicly established in the reviewed sources.
Michele Martello
General Counsel
Joined MDVIP in 2008 and oversees legal matters as General Counsel. Detailed prior-role history was not publicly established in the reviewed sources.
Bret Jorgensen
CEO Emeritus and Board Member
Former CEO and chairman who joined MDVIP in 2009. Became CEO Emeritus and board member after the 2024 planned succession; previously co-founded TheraTx and was twice recognized by EY as Healthcare Entrepreneur of the Year.
Jeffrey Lin, MD, FACC
Chief Medical Officer
Appointed in April 2026. Previously National Medical Director and first physician hire at Devoted Health, where he helped build and scale a clinical model serving more than 400,000 members across 29 states; earlier Assistant Professor of Medicine at Mount Sinai Medical Center and cardiology consultant to the NFL Players Association.